Overview
- Doctors say his tumor cannot be removed, and he is receiving radiation plus EDV-based targeted chemotherapy at a Singapore clinic that uses an approach not approved in the U.S.
- Collins cites an average prognosis of roughly 11 to 14 months under standard care, which guided his decision to try emerging therapies.
- His immediate goal is to slow the disease enough to receive a personalized immunotherapy designed for his specific cancer profile.
- Symptoms surged in August with brain fog and short-term memory loss, and UCLA imaging plus a biopsy showing a 30% growth factor triggered urgent intervention.
- He went public after a deliberately limited September family statement, saying he wants to speak for himself and potentially help others facing glioblastoma.